Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Wave Life Sciences (WVE) Shares Outstanding (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Shares Outstanding for 12 consecutive years, with $192.3 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding rose 24.82% year-over-year to $192.3 million; the TTM value through Mar 2026 reached $192.3 million, up 24.82%, while the annual FY2025 figure was $187.7 million, 22.62% up from the prior year.
  • Shares Outstanding hit $192.3 million in Q1 2026 for Wave Life Sciences, up from $187.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $192.3 million in Q1 2026 and bottomed at $3.9 million in Q3 2022.
  • Average Shares Outstanding over 5 years is $120.6 million, with a median of $122.3 million recorded in 2024.
  • Year-over-year, Shares Outstanding tumbled 92.5% in 2022 and then skyrocketed 2437.89% in 2023.
  • Wave Life Sciences' Shares Outstanding stood at $86.9 million in 2022, then skyrocketed by 37.09% to $119.2 million in 2023, then increased by 28.43% to $153.0 million in 2024, then increased by 22.62% to $187.7 million in 2025, then grew by 2.49% to $192.3 million in 2026.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $192.3 million, $187.7 million, and $160.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.